NCT00001261View on ClinicalTrials.gov

Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 31, 1990

Study Completion Date

July 31, 2002

Conditions

DermatomyositisInclusion Body MyositisPolymyositis

Interventions

DRUG

Gamma Globulin

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH